FIELD: biotechnology.
SUBSTANCE: invention constitutes a medium for cultivating bone marrow cells intended for cellular therapy, including a serum-free nutrient medium, whey protein, insulin, characterised by the fact that the medium for cultivating bone marrow cells contains RPMI-1640 as a serum-free nutrient medium, and contains apolipoprotein A-I in an amount of 5 mcg/ml of the medium, recombinant insulin in an amount of 10 mcg/ml of the medium as whey protein.
EFFECT: invention provides a possibility of reducing the amount and content of xenogenic factors present in the serum-free medium while maintaining the functional activity of the bone marrow cells.
1 cl, 2 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR STIMULATING PROLIFERATIVE ACTIVITY OF BONE MARROW CELLS | 2023 |
|
RU2811901C1 |
METHOD OF CARDIOMYOCYTE SELECTION (VERSIONS) | 2007 |
|
RU2426784C2 |
COMPOSITION FOR SKIN AND MUCOUS MEMBRANES REGENERATION | 2016 |
|
RU2621867C1 |
METHOD OF ASSESSING THE ABILITY OF BREAST CANCER CELLS TO DEDIFFERENTIATE USING THE METHOD OF SPHEROID FORMATION | 2022 |
|
RU2805842C1 |
LOW-SERUM MEDIUM FOR CULTIVATION OF HUMAN FIBROBLASTS | 2011 |
|
RU2493250C2 |
STEM CELL MATERIAL AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2785588C2 |
STEM CELL MATERIAL AND METHOD FOR ITS RECEPTION | 2014 |
|
RU2644650C2 |
METHOD FOR CULTURING HUMAN MESENCHYMAL STEM CELLS EX VIVO | 2006 |
|
RU2323252C1 |
METHOD OF PRE-DIFFERENTIATION OF STROMAL STEM CELLS OF BONE MARROW IN TYROSINE HYDROXYLASE-POSITIVE CELLS | 2014 |
|
RU2567671C1 |
BIOTRANSPLANT, METHOD FOR ITS PREPARING AND METHOD FOR TREATMENT OF CHRONIC HEPATITIS AND LIVER CIRRHOSIS (VARIANTS) | 2004 |
|
RU2272638C1 |
Authors
Dates
2021-10-07—Published
2020-11-09—Filed